# Ecolab Inc.: financial statements, quarterly

ECL · NYSE · CIK 31462 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ecl.md) · [Financials](/companies/ecl/financials.md) · [Filings](/companies/ecl/filings.md) · [Insiders](/companies/ecl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ecl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,938](/filings/0001558370-25-001263.md) | [3,752](/filings/0001558370-25-006969.md) | [3,986](/filings/0001558370-25-010768.md) | [3,999](/filings/0001104659-25-104386.md) | [4,005](/filings/0001558370-25-001263.md) | [3,695](/filings/0001104659-26-056737.md) | [4,025](/filings/0001628280-26-053886.md) | [4,165](/filings/0001628280-26-068208.md) | [4,196 d](/filings/0001104659-26-018357.md) | [4,066](/filings/0001104659-26-056737.md) | [4,415](/filings/0001628280-26-053886.md) | [4,695](/filings/0001628280-26-068208.md) |
| Cost of revenue | $m | [2,284](/filings/0001558370-25-001263.md) | [2,128](/filings/0001558370-25-006969.md) | [2,241](/filings/0001558370-25-010768.md) | [2,262](/filings/0001104659-25-104386.md) | [2,269](/filings/0001558370-25-001263.md) | [2,060](/filings/0001104659-26-056737.md) | [2,223](/filings/0001628280-26-053886.md) | [2,299](/filings/0001628280-26-068208.md) | [2,348 d](/filings/0001104659-26-018357.md) | [2,295](/filings/0001104659-26-056737.md) | [2,470](/filings/0001628280-26-053886.md) | [2,626](/filings/0001628280-26-068208.md) |
| Selling, general and administrative | $m | [1,035](/filings/0001558370-25-001263.md) | [1,078](/filings/0001558370-25-006969.md) | [1,076](/filings/0001558370-25-010768.md) | [1,025](/filings/0001104659-25-104386.md) | [1,050](/filings/0001558370-25-001263.md) | [1,050](/filings/0001104659-26-056737.md) | [1,068](/filings/0001628280-26-053886.md) | [1,079](/filings/0001628280-26-068208.md) | [1,061 d](/filings/0001104659-26-018357.md) | [1,102](/filings/0001104659-26-056737.md) | [1,142](/filings/0001628280-26-053886.md) | [1,177](/filings/0001628280-26-068208.md) |
| Operating income | $m | [590](/filings/0001558370-25-001263.md) | [518](/filings/0001558370-25-006969.md) | [657](/filings/0001558370-25-010768.md) | [1,045](/filings/0001104659-25-104386.md) | [583](/filings/0001558370-25-001263.md) | [555](/filings/0001104659-26-056737.md) | [710](/filings/0001628280-26-053886.md) | [760](/filings/0001628280-26-068208.md) | [712 d](/filings/0001104659-26-018357.md) | [622](/filings/0001104659-26-056737.md) | [758](/filings/0001628280-26-053886.md) | [811](/filings/0001628280-26-068208.md) |
| Interest expense | $m | [94.8 d](/filings/0001104659-26-018357.md) | [94.5](/filings/0001558370-25-006969.md) | [80.2](/filings/0001558370-25-010768.md) | [86.4](/filings/0001104659-25-104386.md) | [79.2 d](/filings/0001104659-26-018357.md) | [72.6](/filings/0001104659-26-056737.md) | [76.2](/filings/0001558370-25-010768.md) | [74.6](/filings/0001104659-25-104386.md) | [82.9 d](/filings/0001104659-26-018357.md) | [77.3](/filings/0001104659-26-056737.md) | [95.0](/filings/0001628280-26-053886.md) | [136](/filings/0001628280-26-068208.md) |
| Income tax | $m | [127](/filings/0001558370-25-001263.md) | [42.3](/filings/0001558370-25-006969.md) | [95.7](/filings/0001558370-25-010768.md) | [247](/filings/0001104659-25-104386.md) | [54.8](/filings/0001558370-25-001263.md) | [104](/filings/0001104659-26-056737.md) | [131](/filings/0001628280-26-053886.md) | [128](/filings/0001628280-26-068208.md) | [91.7 d](/filings/0001104659-26-018357.md) | [122](/filings/0001104659-26-056737.md) | [155](/filings/0001628280-26-053886.md) | [140](/filings/0001628280-26-068208.md) |
| Net income | $m | [405 d](/filings/0001104659-26-018357.md) | [412](/filings/0001558370-25-006969.md) | [491](/filings/0001558370-25-010768.md) | [737](/filings/0001104659-25-104386.md) | [473 d](/filings/0001104659-26-018357.md) | [403](/filings/0001104659-26-056737.md) | [524](/filings/0001628280-26-053886.md) | [585](/filings/0001628280-26-068208.md) | [564 d](/filings/0001104659-26-018357.md) | [433](/filings/0001104659-26-056737.md) | [535](/filings/0001628280-26-053886.md) | [551](/filings/0001628280-26-068208.md) |
| Diluted EPS | $ per share | [1.41](/filings/0001558370-25-001263.md) | [1.43](/filings/0001558370-25-006969.md) | [1.71](/filings/0001558370-25-010768.md) | [2.58](/filings/0001104659-25-104386.md) | [1.66](/filings/0001558370-25-001263.md) | [1.41](/filings/0001104659-26-056737.md) | [1.84](/filings/0001628280-26-053886.md) | [2.05](/filings/0001628280-26-068208.md) | not reported | [1.52](/filings/0001104659-26-056737.md) | [1.90](/filings/0001628280-26-053886.md) | [1.95](/filings/0001628280-26-068208.md) |
| Basic EPS | $ per share | [1.42](/filings/0001558370-25-001263.md) | [1.44](/filings/0001558370-25-006969.md) | [1.72](/filings/0001558370-25-010768.md) | [2.60](/filings/0001104659-25-104386.md) | [1.67](/filings/0001558370-25-001263.md) | [1.42](/filings/0001104659-26-056737.md) | [1.85](/filings/0001628280-26-053886.md) | [2.06](/filings/0001628280-26-068208.md) | not reported | [1.53](/filings/0001104659-26-056737.md) | [1.91](/filings/0001628280-26-053886.md) | [1.97](/filings/0001628280-26-068208.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.9](/filings/0001558370-25-001263.md) | [0.5](/filings/0001558370-24-006535.md) | [0.4](/filings/0001558370-24-010647.md) | [1.3](/filings/0001558370-24-014051.md) | [1.3](/filings/0001104659-26-018357.md) | [1.2](/filings/0001558370-25-006969.md) | [1.9](/filings/0001558370-25-010768.md) | [2.0](/filings/0001104659-25-104386.md) | [0.6](/filings/0001628280-26-068208.md) | [0.5](/filings/0001104659-26-056737.md) | [5.1](/filings/0001628280-26-053886.md) | [0.7](/filings/0001628280-26-068208.md) |
| Current assets | $bn | [5.6](/filings/0001558370-25-001263.md) | [5.2](/filings/0001558370-24-006535.md) | [5.8](/filings/0001558370-24-010647.md) | [6.1](/filings/0001558370-24-014051.md) | [6.0](/filings/0001104659-26-018357.md) | [6.1](/filings/0001558370-25-006969.md) | [7.1](/filings/0001558370-25-010768.md) | [7.1](/filings/0001104659-25-104386.md) | [6.0](/filings/0001628280-26-068208.md) | [6.0](/filings/0001104659-26-056737.md) | [11.0](/filings/0001628280-26-053886.md) | [7.1](/filings/0001628280-26-068208.md) |
| Total assets | $bn | [21.8](/filings/0001558370-25-001263.md) | [21.3](/filings/0001558370-24-006535.md) | [21.5](/filings/0001558370-24-010647.md) | [22.1](/filings/0001558370-24-014051.md) | [22.4](/filings/0001104659-26-018357.md) | [22.4](/filings/0001558370-25-006969.md) | [23.7](/filings/0001558370-25-010768.md) | [23.9](/filings/0001104659-25-104386.md) | [24.7](/filings/0001628280-26-068208.md) | [25.0](/filings/0001104659-26-056737.md) | [29.9](/filings/0001628280-26-053886.md) | [31.1](/filings/0001628280-26-068208.md) |
| Current liabilities | $bn | [4.3](/filings/0001558370-25-001263.md) | [3.7](/filings/0001558370-24-006535.md) | [3.8](/filings/0001558370-24-010647.md) | [4.7](/filings/0001558370-24-014051.md) | [4.8](/filings/0001104659-26-018357.md) | [4.6](/filings/0001558370-25-006969.md) | [4.9](/filings/0001558370-25-010768.md) | [4.2](/filings/0001104659-25-104386.md) | [5.5](/filings/0001628280-26-068208.md) | [6.1](/filings/0001104659-26-056737.md) | [6.0](/filings/0001628280-26-053886.md) | [6.4](/filings/0001628280-26-068208.md) |
| Total liabilities | $bn | [13.8](/filings/0001558370-25-001263.md) | [13.1](/filings/0001558370-24-006535.md) | [13.2](/filings/0001558370-24-010647.md) | [13.5](/filings/0001558370-24-014051.md) | [13.6](/filings/0001104659-26-018357.md) | [13.5](/filings/0001558370-25-006969.md) | [14.4](/filings/0001558370-25-010768.md) | [14.1](/filings/0001104659-25-104386.md) | [14.9](/filings/0001628280-26-068208.md) | [15.0](/filings/0001104659-26-056737.md) | [19.8](/filings/0001628280-26-053886.md) | [20.7](/filings/0001628280-26-068208.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.6](/filings/0001558370-25-001263.md) | [0.0](/filings/0001558370-24-006535.md) | [0.0](/filings/0001558370-24-010647.md) | [0.6](/filings/0001558370-24-014051.md) | [0.6](/filings/0001104659-26-018357.md) | [0.6](/filings/0001558370-25-006969.md) | [0.7](/filings/0001558370-25-010768.md) | [0.0](/filings/0001104659-25-104386.md) | [0.8](/filings/0001628280-26-068208.md) | [1.6](/filings/0001104659-26-056737.md) | [1.3](/filings/0001628280-26-053886.md) | [1.3](/filings/0001628280-26-068208.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-25-104386.md) | not reported | not reported | [0.0](/filings/0001104659-25-104386.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [8.0](/filings/0001558370-25-001263.md) | [8.2](/filings/0001558370-24-006535.md) | [8.3](/filings/0001558370-24-010647.md) | [8.5](/filings/0001558370-24-014051.md) | [8.8](/filings/0001104659-26-018357.md) | [8.9](/filings/0001558370-25-006969.md) | [9.3](/filings/0001558370-25-010768.md) | [9.7](/filings/0001104659-25-104386.md) | [9.8](/filings/0001628280-26-068208.md) | [10.0](/filings/0001104659-26-056737.md) | [10.1](/filings/0001628280-26-053886.md) | [10.4](/filings/0001628280-26-068208.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [853 d](/filings/0001104659-26-018357.md) | [649](/filings/0001558370-25-006969.md) | [611 d](/filings/0001558370-25-010768.md) | [787 d](/filings/0001104659-25-104386.md) | [767 d](/filings/0001104659-26-018357.md) | [369](/filings/0001104659-26-056737.md) | [702 d](/filings/0001628280-26-053886.md) | [791 d](/filings/0001628280-26-068208.md) | [1,090 d](/filings/0001104659-26-018357.md) | [446](/filings/0001104659-26-056737.md) | [730 d](/filings/0001628280-26-053886.md) | [764 d](/filings/0001628280-26-068208.md) |
| Capital expenditure | $m | [263 d](/filings/0001104659-26-018357.md) | [202](/filings/0001558370-25-006969.md) | [197 d](/filings/0001558370-25-010768.md) | [236 d](/filings/0001104659-25-104386.md) | [360 d](/filings/0001104659-26-018357.md) | [238](/filings/0001104659-26-056737.md) | [217 d](/filings/0001628280-26-053886.md) | [262 d](/filings/0001628280-26-068208.md) | [332 d](/filings/0001104659-26-018357.md) | [349](/filings/0001104659-26-056737.md) | [240 d](/filings/0001628280-26-053886.md) | [313 d](/filings/0001628280-26-068208.md) |
| Dividends paid | $m | [155 d](/filings/0001104659-26-018357.md) | [175](/filings/0001558370-25-006969.md) | [166 d](/filings/0001558370-25-010768.md) | [162 d](/filings/0001104659-25-104386.md) | [161 d](/filings/0001104659-26-018357.md) | [192](/filings/0001104659-26-056737.md) | [188 d](/filings/0001628280-26-053886.md) | [184 d](/filings/0001628280-26-068208.md) | [189 d](/filings/0001104659-26-018357.md) | [216](/filings/0001104659-26-056737.md) | [208 d](/filings/0001628280-26-053886.md) | [205 d](/filings/0001628280-26-068208.md) |
| Share repurchases | $m | [2.0 d](/filings/0001104659-26-018357.md) | [196](/filings/0001558370-25-006969.md) | [323 d](/filings/0001558370-25-010768.md) | [464 d](/filings/0001104659-25-104386.md) | [2.8 d](/filings/0001104659-26-018357.md) | [154](/filings/0001104659-26-056737.md) | [45.5 d](/filings/0001628280-26-053886.md) | [175 d](/filings/0001628280-26-068208.md) | [409 d](/filings/0001104659-26-018357.md) | [344](/filings/0001104659-26-056737.md) | [325 d](/filings/0001628280-26-053886.md) | [2.8 d](/filings/0001628280-26-068208.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [287](/filings/0001558370-25-001263.md) | [287](/filings/0001558370-25-001263.md) | [288](/filings/0001558370-25-006969.md) | [287](/filings/0001558370-25-010768.md) | [286](/filings/0001104659-25-104386.md) | [286](/filings/0001558370-25-001263.md) | [285](/filings/0001104659-26-056737.md) | [285](/filings/0001628280-26-053886.md) | [285](/filings/0001628280-26-068208.md) | [284](/filings/0001104659-26-056737.md) | [282](/filings/0001628280-26-053886.md) | [282](/filings/0001628280-26-068208.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 280,467,785 at 2026-09-30, from the cover of the [10-Q filed 2026-10-29](/filings/0001628280-26-068208.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 16:39 ET. No prices; not investment advice.